# Safety Study of AZD5672 in Renally Impaired Subjects

> **NCT00715702** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 40 (estimated)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** AZD5672

## Key facts

- **NCT ID:** NCT00715702
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2009-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00715702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00715702, "Safety Study of AZD5672 in Renally Impaired Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00715702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*